Empathy Gaps, Moral Hazards
Medicine has become a vast system. As it grew, we lost empathy for patients and replaced it with a nexus ...
Medicine is a Duty, Not a Right
Rights force us to think individually. But medicine is a duty. It works only when we think of service to ...
Healthcare Has Always Been Political
Recent political tensions have put a strain on healthcare. This is nothing new. Throughout history, politics have influenced healthcare and ...
Hearing Aids for the Masses
Select over the counter hearing aids will be available soon. The move aims to lower costs. Instead, it will reveal ...
History of Medical Jurisprudence
We delve into the woefully understudied discipline and glean the perspective of the physician luminary, Dr. William Osler.
Will Drug Prices Actually Fall?
The Inflation Reduction Act promises to reduce drug prices. But the law is more financial gamesmanship than true patient advocacy, ...
I joined an abortion clinic protest
We spoke with protesters outside of an abortion clinic to understand their position on abortion and their purpose for protesting. ...
A Pox On All Vaccines
Misinformation is a mistake of our own making. It leads to vaccine hesitancy and mistrust among patients. It also exposes ...
DOJ’s Abortion Activism
The DOJ has been actively supporting abortion access. This may appear good, but it becomes concerning when we define medical ...
Healthcare’s False Starts
Healthcare seems to repeat many mistakes lately. Beneath the rhetoric lives an uncomfortable truth. These mistakes are not a problem, ...
End of Evidence-Based Medicine
Recent findings have challenged our understanding of depression and dementia. They should also raise questions about our reliance on evidence-based ...
Amazon’s Clinical Tell
Amazon acquired One Medical, a chain of concierge primary care clinics. The move expands Amazon's presence in virtual primary care. ...
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more